Evidence map›Paper›PMID 40351906›Full record

ArticleCureus2025

Diagnostic Challenges in Intracranial Rosai-Dorfman Disease: Differentiating It From Meningiomas Using Imaging.

Jad F Mourad, Mark Bryniarski

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jad F MouradDepartment of Neuroscience, Burrell College of Osteopathic Medicine, Las Cruces, USA.
Mark BryniarskiDepartment of Neuroscience, Burrell College of Osteopathic Medicine, Las Cruces, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosai-Dorfman disease (RDD) is a rare non-Langerhans cell histiocytosis (non-LCH) with intracranial involvement being exceptionally uncommon. We report a 45-year-old woman presenting with neurological symptoms initially suggestive of a stroke, later found to have a dural-based lesion resembling a meningioma. MRI revealed a mixed T1 isointense to hyperintense and T2 hyperintense mass with restricted diffusion on diffusion-weighted imaging (DWI) and lower apparent diffusion coefficient (ADC) values, findings atypical for meningiomas. Intracranial RDD commonly mimics meningiomas radiographically but can be distinguished by unique imaging features. Surgical resection remains the treatment of choice for isolated lesions, though recurrence is possible. This case highlights the importance of recognizing RDD in the differential diagnosis of dural-based lesions to ensure accurate diagnosis and tailored management.

Indexed as

adcdwiintracranialmeningiomamrineurosurgeryrosai-dorfman

Identifiers

PMID40351906
PMCPMC12066108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.